CADET BRAF Mutation Test
This panel evaluates C-Kit and Ki-67 (IHC), C-Kit mutations (PCR), and AgNOR staining to assess the aggressiveness of canine mast cell tumors.
Prognostic molecular mammary tumour panel
Pet cancer diagnostics utilize advanced molecular, cytological, and immunohistochemical techniques to identify and monitor cancer. These methods focus on genetic alterations, cell behavior, and tumor markers to offer precise detection, prognostication, and personalized treatment options.
Cancer Diagnostics
A non-invasive, highly specific (100%) method for diagnosing canine TCC, UC, and PC, enabling earlier detection and timely intervention. Not suitable for use in cats
Flow cytometry
An advanced method to analyze cell size and surface proteins, crucial for diagnosing and immunophenotyping cancer in dogs. Limited utility in cats due to antibody availability.
Immunohistochemistry (IHC)
This is a precise diagnostic tool for identifying tumors and infectious organisms. For details, refer to the IHC Menu or contact the team.
Mast Cell Tumor Prognostic Panel
Melanoma Panel – Complete (IHC)
A comprehensive diagnostic panel with key markers (Melan A, PNL-2, TRP-1, TRP-2) and Ki-67 IHC analysis to evaluate and predict the aggressiveness of canine melanoma.
PCR for Antigen Receptor Rearrangement (PARR)
A molecular based test to distinguish between reactive and neoplastic lymphoid proliferations, aiding in the diagnosis of lymphoma or leukemia when cytology or histopathology is inconclusive.
Parathyroid Hormone Related Protein (PTHrp)
A key biomarker for diagnosing hypercalcemia, distinguishing malignancy-associated cases from primary hyperparathyroidism and other calcium metabolism disorders.
This Mammary Tumor Panel analyzes nine key markers to assess the behavior of mammary tumors in dogs.
Protein Electrophoresis
This diagnostic technique that separates proteins to identify abnormalities in albumin and globulins, aiding in the detection of neoplastic, inflammatory, and immune-mediated diseases in dogs.